PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Propamidine→

Propamidine PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
104-32-5
Molecular formula
C17H20N4O2
Molecular weight
312.37 g/mol
Drug class
Aromatic diamidine antiseptictopical antimicrobial agent
Mechanism of action
Interacts with microbial nucleic acids and cellular components, disrupting essential microbial processes. The exact mechanism varies by organism and is not fully defined; topical use is limited to selected ocular and local infections.
Indications / reported uses
  • Topical treatment of selected superficial eye infections, including bacterial conjunctivitis, using authorised ophthalmic formulations; systemic infection indications should not be inferred

Sources: NHS — Propamidine isetionate eye drops · NLM MeSH — Propamidine · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Propamidine PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Propamidine Permitted Daily Exposure (PDE) report (the Propamidine PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Propamidine Occupational Exposure Limit (OEL) report (the Propamidine OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.